Literature DB >> 14762843

Obesity and diabetes as a risk factor for hepatocellular carcinoma.

Jean M Regimbeau1, Magali Colombat, Philippe Mognol, François Durand, Eddie Abdalla, Claude Degott, Françoise Degos, Olivier Farges, Jacques Belghiti.   

Abstract

Ten percent of patients who undergo resection for hepatocellular carcinoma (HCC) associated with chronic liver disease have no detectable cause for this underlying liver disease. Recent studies have shown that patients with cryptogenic chronic liver disease frequently have risk factors for nonalcoholic fatty liver disease (NAFLD). This study examines the incidence of risk factors for NAFLD in patients with chronic liver disease who underwent resection for HCC. Among 210 patients with chronic liver disease who underwent resection for HCC, 18 (8.6%) had no identifiable cause for the underlying liver disease. These patients were assessed for obesity, diabetes mellitus, and histological features of the tumor and the adjacent liver parenchyma. Comparisons were made with matched patients with alcohol- and chronic-viral-hepatitis-related HCC. The prevalence of obesity (50% vs. 17% vs. 14%), diabetes (56% vs. 17% vs. 11%), aspartate aminotransferase/alanine aminotransferase ratio<1 (50% vs. 19% vs. 17%), and steatosis>20% (61% vs. 17% vs. 19%) was significantly higher in patients with cryptogenic liver disease than in patients with alcohol abuse and chronic viral hepatitis (P<0.0001 for each). Well-differentiated tumors were significantly more common in patients with cryptogenic liver disease (89% vs. 64% in patients with alcohol-related HCC vs. 55% in patients with chronic viral hepatitis-related HCC, P<0.0001). In conclusion, the hypothesis that obesity and diabetes mellitus may be important risk factors for cryptogenic chronic liver disease in patients with HCC is supported by the analysis of surgically treated patients. Whether HCC is primarily related to obesity and diabetes mellitus or secondarily to a NAFLD-like parenchymal lesions remains to be clarified.

Entities:  

Mesh:

Year:  2004        PMID: 14762843     DOI: 10.1002/lt.20033

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  55 in total

1.  Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.

Authors:  M Sherman; K Burak; J Maroun; P Metrakos; J J Knox; R P Myers; M Guindi; G Porter; J R Kachura; P Rasuli; S Gill; P Ghali; P Chaudhury; J Siddiqui; D Valenti; A Weiss; R Wong
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

2.  Potential role of leptin expression in hepatocellular carcinoma.

Authors:  S-N Wang; Y-T Yeh; S-F Yang; C-Y Chai; K-T Lee
Journal:  J Clin Pathol       Date:  2006-03-24       Impact factor: 3.411

Review 3.  Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.

Authors:  Amit D Tevar; Calissia Clarke; Jiang Wang; Steven M Rudich; E Steve Woodle; Alex B Lentsch; Michael L Edwards
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

4.  Laparoscopic liver resection in obese patients.

Authors:  Kan Toriguchi; Etsuro Hatano; Takaki Sakurai; Satoru Seo; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

Review 5.  Non-viral causes of hepatocellular carcinoma.

Authors:  Wojciech Blonski; David S Kotlyar; Kimberly A Forde
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

6.  Non-viral factors contributing to hepatocellular carcinoma.

Authors:  Manal A Hamed; Sanaa A Ali
Journal:  World J Hepatol       Date:  2013-06-27

Review 7.  Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

Authors:  Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

8.  Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings.

Authors:  Michele Di Martino; Luca Saba; Sandro Bosco; Massimo Rossi; Kirchin A Miles; Rossella Di Miscio; Concetta Valentina Lombardo; Elisabetta Tamponi; Mario Piga; Carlo Catalano
Journal:  Eur Radiol       Date:  2014-04-26       Impact factor: 5.315

9.  Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.

Authors:  Sahil Mittal; Yvonne H Sada; Hashem B El-Serag; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-19       Impact factor: 11.382

Review 10.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.